Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02806024 · ClinicalTrials.gov registry record · Phase 4
Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study
A Phase 4 study of Postpartum Hemorrhage and Cesarean Section, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 4
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT02806024: Completed Phase 4 study of Postpartum Hemorrhage and Cesarean Section, sponsored by University of California, San Francisco.
NCT02806024 is a Phase 4 study of Postpartum Hemorrhage and Cesarean Section that has completed, run by University of California, San Francisco. The registered enrollment target is 14 participants, below the 779-participant average among 19 other Postpartum Hemorrhage trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02806024, a Phase 4 study of Postpartum Hemorrhage and Cesarean Section, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this pilot study is to determine if intravenous tranexamic acid (TXA) is effective for reducing blood loss during high risk surgical procedures related to placenta previa and placenta accreta. TXA is currently used in other types of surgery for patients who are expected to have a large blood loss, such as orthopedic or open heart surgery.
Primary Outcome
EBL is estimated by the surgeon and anesthesia team at the completion of the surgery (cesarean delivery \&/or cesarean hysterectomy).
Conditions Studied
Interventions
- DRUG Tranexamic Acid
- DRUG Placebo Drug
Study Locations (1)
California
- Community Regional Medical Center - Fresno
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2016-11 |
| Est. Completion | 2018-08 |
| Phase | Phase 4 |
What the finished NCT02806024 record still lists
NCT02806024 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 779-participant average among 19 other Postpartum Hemorrhage trials with a reported enrollment target (98% lower).
The record links to 4 conditions, with Postpartum Hemorrhage appearing as the primary indexed condition, and to 2 interventions - of which Tranexamic Acid is the first listed.
NCT02806024 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02806024 about?
NCT02806024 is a clinical study titled "Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study". The purpose of this pilot study is to determine if intravenous tranexamic acid (TXA) is effective for reducing blood loss during high risk surgical procedures related to placenta previa and placenta accreta. TXA is currently used in other types of surgery for patients who are expected to have a larg...
What is the current status of trial NCT02806024?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 14 participants. The study started on 2016-11. Estimated completion is 2018-08.
What conditions does trial NCT02806024 study?
This clinical trial studies the following conditions: Postpartum Hemorrhage, Cesarean Section, Tranexamic Acid, Placenta Accreta.
What interventions are being tested in trial NCT02806024?
The interventions under investigation include: Tranexamic Acid (DRUG), Placebo Drug (DRUG).
Who is sponsoring clinical trial NCT02806024?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02806024 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postpartum Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02806024's enrollment target sits among peer trials
14 20th of 19 the lowest of 19 other Postpartum Hemorrhage trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postpartum Hemorrhage trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Prophylactic Methylergonovine for Twin Cesarean
COMPLETED · Phase 4
-
Prospective Effect of Intravenous Ketorolac on Opioid Use, EBL and Complications Following Cesarean Delivery
COMPLETED · Phase 4
-
Safety and Effectiveness of the KOKO Device to Treat Primary Abnormal Postpartum Uterine Bleeding or Hemorrhage
RECRUITING · NA
-
Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage
RECRUITING · Phase 3
-
Oxytocin Pharmacokinetics and Pharmacodynamics
RECRUITING · Phase 2
-
A Pragmatic Randomized Controlled Trial to Predict Postpartum Hemorrhage
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia